Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM?

作者信息

Taylor S I, Accili D, Imai Y

机构信息

Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.

出版信息

Diabetes. 1994 Jun;43(6):735-40. doi: 10.2337/diab.43.6.735.

DOI:10.2337/diab.43.6.735

PMID:8194657

Abstract

摘要

相似文献

Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM?

Diabetes. 1994 Jun;43(6):735-40. doi: 10.2337/diab.43.6.735.

Insulin deficiency vs insulin resistance in NIDDM: concluding remarks by a 'biased' observer.非胰岛素依赖型糖尿病中的胰岛素缺乏与胰岛素抵抗：一位“有偏见”观察者的总结发言

Diabet Med. 1996 Sep;13(9 Suppl 6):S161-4.

[Significance of insulin measurement in subjects with impaired glucose tolerance or type 2 diabetes].[胰岛素测定在糖耐量受损或2型糖尿病患者中的意义]

Nihon Rinsho. 2005 Feb;63 Suppl 2:361-5.

From sand rats to diabetic patients: is non-insulin-dependent diabetes mellitus a disease of the beta cell?从沙鼠到糖尿病患者：非胰岛素依赖型糖尿病是一种β细胞疾病吗？

Diabetes Metab. 1997 Mar;23 Suppl 2:47-51.

Is the insulin resistance of patients with noninsulin-dependent diabetes mellitus secondary to insulin deficiency?非胰岛素依赖型糖尿病患者的胰岛素抵抗是继发于胰岛素缺乏吗？

Horm Metab Res. 1986 Apr;18(4):244-6. doi: 10.1055/s-2007-1012284.

Glucose toxicity: the implications of hyperglycemia in the pathophysiology of diabetes mellitus.葡萄糖毒性：高血糖在糖尿病病理生理学中的影响。

Clin Invest Med. 1995 Aug;18(4):255-60.

Role of insulin resistance in the pathogenesis of NIDDM.胰岛素抵抗在非胰岛素依赖型糖尿病发病机制中的作用。

Diabetologia. 1995 Dec;38(12):1378-88. doi: 10.1007/BF00400597.

Insulin deficiency and insulin resistance in the pathogenesis of NIDDM: is a divorce possible?胰岛素缺乏与胰岛素抵抗在非胰岛素依赖型糖尿病发病机制中的作用：二者能否分离？

Diabetologia. 1995 Aug;38(8):992-7. doi: 10.1007/BF00400591.

Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects.非胰岛素依赖型糖尿病中的胰岛素抵抗与胰岛素缺乏：问题与前景

Endocr Rev. 1998 Aug;19(4):477-90. doi: 10.1210/edrv.19.4.0336.

Pathophysiology of prediabetes.糖尿病前期的病理生理学。

J Indian Med Assoc. 2005 Nov;103(11):594-5, 599.

引用本文的文献

PARN Maintains RNA Stability to Regulate Insulin Maturation and GSIS in Pancreatic β Cells.PARN 维持 RNA 稳定性以调节胰腺 β 细胞中的胰岛素成熟和 GSIS。

Adv Sci (Weinh). 2024 Nov;11(42):e2407774. doi: 10.1002/advs.202407774. Epub 2024 Sep 19.

Acute Effects of Dietary Protein Consumption on the Postprandial Metabolic Response, Amino Acid Levels and Circulating MicroRNAs in Patients with Obesity and Insulin Resistance.膳食蛋白质摄入对肥胖和胰岛素抵抗患者餐后代谢反应、氨基酸水平和循环 microRNAs 的急性影响。

Int J Mol Sci. 2024 Jul 14;25(14):7716. doi: 10.3390/ijms25147716.

ROCK1 regulates insulin secretion from β-cells.ROCK1 调节β细胞的胰岛素分泌。

Mol Metab. 2022 Dec;66:101625. doi: 10.1016/j.molmet.2022.101625. Epub 2022 Oct 29.

Synthesis, In Vitro Anti-Microbial Analysis and Molecular Docking Study of Aliphatic Hydrazide-Based Benzene Sulphonamide Derivatives as Potent Inhibitors of α-Glucosidase and Urease.基于脂肪族酰肼的苯磺酰胺衍生物的合成、体外抗微生物分析和分子对接研究作为α-葡萄糖苷酶和脲酶的有效抑制剂。

Molecules. 2022 Oct 21;27(20):7129. doi: 10.3390/molecules27207129.

Importance of Heparan Sulfate Proteoglycans in Pancreatic Islets and β-Cells.硫酸乙酰肝素蛋白聚糖在胰岛和β细胞中的重要性。

Int J Mol Sci. 2022 Oct 11;23(20):12082. doi: 10.3390/ijms232012082.

YiQi YangYin Decoction Attenuates Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Rats.益气养阴汤减轻2型糖尿病大鼠非酒精性脂肪性肝病

Evid Based Complement Alternat Med. 2021 Sep 28;2021:5511019. doi: 10.1155/2021/5511019. eCollection 2021.

Insulin signaling in the whole spectrum of GH deficiency.全谱生长激素缺乏症中的胰岛素信号传导

Arch Endocrinol Metab. 2019 Nov-Dec;63(6):582-591. doi: 10.20945/2359-3997000000188.

, and Extracts Modulate the Insulin Receptor Expression and Improve Hepatic Steatosis in NAFLD Patients: A Pilot Clinical Trial.及提取物可调节胰岛素受体表达，改善非酒精性脂肪性肝病患者的肝脂肪变性：一项初步临床试验。

Nutrients. 2019 Dec 16;11(12):3070. doi: 10.3390/nu11123070.

Adenine nucleotide-mediated regulation of hepatic PTP1B activity in mouse models of type 2 diabetes.腺嘌呤核苷酸介导的 2 型糖尿病小鼠模型中肝 PTP1B 活性的调节。

Diabetologia. 2019 Nov;62(11):2106-2117. doi: 10.1007/s00125-019-04971-1. Epub 2019 Aug 13.

YH18968, a Novel 1,2,4-Triazolone G-Protein Coupled Receptor 119 Agonist for the Treatment of Type 2 Diabetes Mellitus.YH18968，一种用于治疗2型糖尿病的新型1,2,4-三唑酮G蛋白偶联受体119激动剂。

Biomol Ther (Seoul). 2018 Mar 1;26(2):201-209. doi: 10.4062/biomolther.2018.011.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验